Hyperuricemia and Risk of Stroke: a Systematic Review and Meta-analysis

Overview

Journal Arthritis Rheum

Specialty Rheumatology

Date 2009 Jul 1

PMID 19565556

Citations 176

Authors

Seo Young Kim

James P Guevara

Kyoung Mi Kim

Hyon K Choi

Daniel F Heitjan

Daniel A Albert

Affiliations

Soon will be listed here.

Abstract

Objective: To assess the association between hyperuricemia and risk of stroke incidence and mortality because hyperuricemia is hypothesized to be a risk factor for stroke and other cardiovascular disease, but, to date, results from observational studies are conflicting.

Methods: A systematic review and meta-analysis were conducted. Studies were identified by searching major electronic databases using the Medical Subject Headings and keywords without restriction in languages. Prospective cohort studies were included only if they contained data on stroke incidences or mortalities related to serum uric acid levels in adults. Pooled risk ratios (RRs) for the association of stroke incidence and mortality with serum uric acid levels were calculated.

Results: A total of 16 studies including 238,449 adults were eligible and abstracted. Hyperuricemia was associated with a significantly higher risk of both stroke incidence (6 studies; RR 1.41, 95% confidence interval [95% CI] 1.05, 1.76) and mortality (6 studies; RR 1.36, 95% CI 1.03, 1.69) in our meta-analyses of unadjusted study estimates. Subgroup analyses of studies adjusting for known risk factors such as age, hypertension, diabetes mellitus, and cholesterol still showed that hyperuricemia was significantly associated with both stroke incidence (4 studies; RR 1.47, 95% CI 1.19, 1.76) and mortality (6 studies; RR 1.26, 95% CI 1.12, 1.39). The pooled estimate of multivariate RRs did not differ significantly by sex.

Conclusion: Hyperuricemia may modestly increase the risks of both stroke incidence and mortality. Future research is needed to determine whether lowering uric acid level has any beneficial effects on stroke.

Citing Articles

Spatiotemporal landscape of kidney in a mouse model of hyperuricemia at single-cell level.

Chang H, Tao Q, Wei L, Wang Y, Tu C FASEB J. 2025; 39(2):e70292.

PMID: 39817712 PMC: 11737292. DOI: 10.1096/fj.202401801RR.

Gout and Hyperuricemia: A Narrative Review of Their Comorbidities and Clinical Implications.

Timsans J, Palomaki A, Kauppi M J Clin Med. 2025; 13(24.

PMID: 39768539 PMC: 11678569. DOI: 10.3390/jcm13247616.

U-shaped relationship between uric acid levels and all-cause mortality in patients with hypertension.

Huang Y, Li J, Sun F, Zhou H, Jiang H, Chen L Sci Rep. 2025; 15(1):97.

PMID: 39747209 PMC: 11697446. DOI: 10.1038/s41598-024-83831-4.

Association between oral health and hyperuricemia in Korean adults: Korea National Health and Nutrition Examination Survey 2016-2019.

Park J, Son M, Lee S, Chung W, Lee S Korean J Intern Med. 2024; 39(6):1001-1010.

PMID: 39434607 PMC: 11569917. DOI: 10.3904/kjim.2023.425.

A New Perspective on the Prediction and Treatment of Stroke: The Role of Uric Acid.

Zhu B, Huang X, Zhang J, Wang X, Tian S, Zhan T Neurosci Bull. 2024; 41(3):486-500.

PMID: 39312108 PMC: 11876515. DOI: 10.1007/s12264-024-01301-3.

References

Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N . Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007; 117(4):e25-146. DOI: 10.1161/CIRCULATIONAHA.107.187998. View

Mazzali M, Hughes J, Kim Y, Jefferson J, Kang D, Gordon K . Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001; 38(5):1101-6. DOI: 10.1161/hy1101.092839. View

Hozawa A, Folsom A, Ibrahim H, Nieto F, Rosamond W, Shahar E . Serum uric acid and risk of ischemic stroke: the ARIC Study. Atherosclerosis. 2005; 187(2):401-7. DOI: 10.1016/j.atherosclerosis.2005.09.020. View

Strasak A, Kelleher C, Brant L, Rapp K, Ruttmann E, Concin H . Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. Int J Cardiol. 2008; 125(2):232-9. DOI: 10.1016/j.ijcard.2007.11.094. View

Mazza A, Pessina A, Pavei A, Scarpa R, Tikhonoff V, Casiglia E . Predictors of stroke mortality in elderly people from the general population. The CArdiovascular STudy in the ELderly. Eur J Epidemiol. 2003; 17(12):1097-104. DOI: 10.1023/a:1021216713504. View

Fang J, Alderman M . Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA. 2000; 283(18):2404-10. DOI: 10.1001/jama.283.18.2404. View

Johnson R, Kang D, Feig D, Kivlighn S, Kanellis J, Watanabe S . Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?. Hypertension. 2003; 41(6):1183-90. DOI: 10.1161/01.HYP.0000069700.62727.C5. View

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

Hsu S, Pai M, Peng Y, Chiang C, Ho T, Hung K . Serum uric acid levels show a 'J-shaped' association with all-cause mortality in haemodialysis patients. Nephrol Dial Transplant. 2004; 19(2):457-62. DOI: 10.1093/ndt/gfg563. View

10.

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

11.

Kanellis J, Feig D, Johnson R . Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed. Nephrology (Carlton). 2005; 9(6):394-9. DOI: 10.1111/j.1440-1797.2004.00336.x. View

12.

Becker M, Schumacher Jr H, Wortmann R, MacDonald P, Eustace D, Palo W . Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med. 2005; 353(23):2450-61. DOI: 10.1056/NEJMoa050373. View

13.

Longo-Mbenza B, Luila E, Mbete P, Vita E . Is hyperuricemia a risk factor of stroke and coronary heart disease among Africans?. Int J Cardiol. 1999; 71(1):17-22. DOI: 10.1016/s0167-5273(99)00097-2. View

14.

Viazzi F, Parodi D, Leoncini G, Parodi A, Falqui V, Ratto E . Serum uric acid and target organ damage in primary hypertension. Hypertension. 2005; 45(5):991-6. DOI: 10.1161/01.HYP.0000161184.10873.ea. View

15.

Baker J, Krishnan E, Chen L, Schumacher H . Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?. Am J Med. 2005; 118(8):816-26. DOI: 10.1016/j.amjmed.2005.03.043. View

16.

Butler R, Morris A, Belch J, Hill A, Struthers A . Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension. 2000; 35(3):746-51. DOI: 10.1161/01.hyp.35.3.746. View

17.

Proctor P . Uric acid: neuroprotective or neurotoxic?. Stroke. 2008; 39(5):e88. DOI: 10.1161/STROKEAHA.107.513242. View

18.

Baker J, Schumacher H, Krishnan E . Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial. Angiology. 2007; 58(4):450-7. DOI: 10.1177/0003319707303444. View

19.

Mazzali M, Kanellis J, Han L, Feng L, Chen Q, Kang D . Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol. 2002; 282(6):F991-7. DOI: 10.1152/ajprenal.00283.2001. View

20.

Feig D, Kang D, Johnson R . Uric acid and cardiovascular risk. N Engl J Med. 2008; 359(17):1811-21. PMC: 2684330. DOI: 10.1056/NEJMra0800885. View